Riskpilot← Back to searchSign inGet full accessPHARMADANICA A/S
A/SActiveCVR 19056007Vassingerødvej 9Wholesale of pharmaceutical and medical goods · NACE 4646Est. 1996— employees
Revenue 2025
—
EBITDA margin
—
-12% vs 2024
Equity ratio
91.6%
Financial strength
Net profit 2025
DKK -340K
-2156% vs 2024
| Revenue | — | — |
| EBITDA | DKK -30K | -12% |
| Net profit | DKK -340K | -2156% |
| Total assets | DKK 18,2M | -5% |
| Equity | DKK 16,6M | -5% |
| Employees | — | — |
Legal name
PHARMADANICA A/S
CVR number
19056007
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. januar 1996
Share capital
DKK 1.000.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2025-03-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer i forening, eller af to direktører i forening, eller af den samlede bestyrelse
Company purpose
Selskabets formål er at drive handel og industri
Address
Vassingerødvej 9
Phone
+4548163200
Email
info@missionpharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -30 | -3 | -21 | — | — | — | — | — | — | — | — | — | — | — |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -30 | -3 | -21 | -14 | -19 | -3 | 0 | -11 | -11 | -20 | -12 | -33 | -26 | -30 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -30 | -3 | -21 | -14 | -19 | -3 | 0 | -11 | -11 | -20 | -12 | -33 | -26 | -30 |
| Net financials | -853 | -112 | -32 | 2.513 | -4 | 12.858 | -5 | 3.335 | -767 | -781 | 489 | -1.025 | 11 | -312 |
| Profit before tax | -883 | -114 | -52 | 2.499 | -23 | 12.855 | -5 | 3.324 | -778 | -801 | 478 | -1.058 | -16 | -342 |
| Tax | -11 | -29 | -13 | -4 | -5 | 2 | -1 | -1 | -1 | -9 | 2 | -3 | -1 | -2 |
| Net profit | -873 | -86 | -40 | 2.503 | -18 | 12.853 | -4 | 3.325 | -777 | -792 | 476 | -1.055 | -15 | -340 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.186 | 57 | 997 | 3.500 | 3.492 | 17.828 | 17.825 | 21.168 | 20.401 | 19.618 | 20.104 | 19.078 | 19.038 | 18.172 |
| Equity | -685 | -771 | 989 | 3.492 | 3.475 | 16.328 | 16.324 | 19.649 | 18.872 | 18.080 | 18.556 | 17.501 | 17.486 | 16.646 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.872 | 828 | 8 | 8 | 17 | 1.500 | 1.500 | 1.518 | 1.528 | 1.538 | 1.548 | 1.577 | 1.552 | 1.526 |
| Total debt | 2.872 | 828 | 8 | 8 | 17 | 1.500 | 1.500 | 1.518 | 1.528 | 1.538 | 1.548 | 1.577 | 1.552 | 1.526 |
EBITDA margin
-2953800.0%
This company
15.8%
Market median
-18695037% vs market
20122025
Equity ratio
91.6%
This company
38.2%
Market median
+140% vs market
20122025
Return on equity
-2.0%
This company
18.4%
Market median
-111% vs market
20122025
Net profit margin
-33964700.0%
This company
8.1%
Market median
-419317384% vs market
20122025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via CVR / Virk · Period 2020-04-01 – 2021-03-31
- Annual report 2020Filed via CVR / Virk · Period 2019-04-01 – 2020-03-31
- Annual report 2019Filed via CVR / Virk · Period 2018-04-01 – 2019-03-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-03-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-05-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CM Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
PL Management | Management | 2012 | — | — |
FA Management | Management | 2000 | — | — |
AP Management | Management | 2021 | — | — |
ET | Audit | 1996 | — | — |
NH Audit | Audit | 1996 | — | — |
MM Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
PE Management | Management | 1996 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2001 | — | — | |
| Chairman | 1996 | — | — | |
| Board of Directors | 2003 | — | — | |
| Board of Directors | 2003 | — | — | |
| Board of Directors | 1996 | — | — | |
| Chairman | 2012 | — | — | |
| Board of Directors | 1996 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2012 | — | — | |
| Deputy Chairman | 2012 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 1998 | — | — | |
| Board of Directors | 1996 | — | — | |
| Chairman | 1999 | — | — | |
| Board of Directors | 1996 | — | — | |
| Deputy Chairman | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
MISSIONPHARMA A/S | Company | 100.0% | 100.0% | 2002 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MISSIONPHARMA A/S
PHARMADANICA A/S Board members of PHARMADANICA A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christian Monrad Overgaard | Chief Executive Officer | 0 companies |
| Poul Lindof | Management | 0 companies |
| Flemming Arklint Hansen | Management | 0 companies |
| Alexandre Pierre Jean Vialatte | Management | 0 companies |
| Erik Tronborg Andersen | Audit | 0 companies |
| Niels Harder | Audit | 0 companies |
| Mikkel Mørkedal Wakefield | Chief Executive Officer | 0 companies |
| Per Emil Hasselbalch Stakemann | Management | 0 companies |
| Alan Per Binau | Board of Directors | 0 companies |
| Ulf Svejgaard Poulsen | Chairman | 0 companies |
| Didier Jean-Pierre Yves Klemp | Board of Directors | 0 companies |
| Laurent Bernard Lombart | Board of Directors | 0 companies |
| Erik Schou Stavnstrup | Board of Directors | 0 companies |
| Jean-Marc Pierre Rene Leccia | Chairman | 0 companies |
| Jens Vagn Nielsen | Board of Directors | 0 companies |
| Patricia Hec | Board of Directors | 0 companies |
| Annie Renée Simonne Dateu | Board of Directors | 0 companies |
| Eric Pierre Jean Muris | Board of Directors | 0 companies |
| Denis Georges Fernand Maurice | Deputy Chairman | 0 companies |
| Aymeric Erouart | Board of Directors | 0 companies |
| Ilona Maureen Fischer | Board of Directors | 0 companies |
| Jesper Ahlmann Funding Andersen | Board of Directors | 0 companies |
| Leif Ole Lund-Andersen | Board of Directors | 0 companies |
| Paule Georgette Ginnerup | Chairman | 0 companies |
| Hans Christian Galst | Board of Directors | 0 companies |
| Kim Erik Ginnerup | Deputy Chairman | 0 companies |